RENX Seeks Shareholder Nod for Massive Dilution Post-Private Placement

TL;DR

**RENX is asking shareholders to approve massive dilution from recent financing, vote 'FOR' or risk Nasdaq non-compliance and further uncertainty.**

AI Summary

Safe & Green Development Corp (RENX) is seeking stockholder approval for two critical proposals related to its private placement offering that closed on October 17, 2025. The first proposal, the Series B Conversion Proposal, requests approval for the issuance of up to 53,925,620 shares of common stock upon the conversion of 360,000 shares of Series B Non-Voting Convertible Preferred Stock. This conversion assumes the conversion price is reduced to the floor price due to dilutive issuances or reset provisions, and includes shares for dividends and make-whole provisions. The second proposal, the Warrant Exercise Proposal, seeks approval for the issuance of up to 37,190,083 shares of common stock upon the exercise of common warrants issued in the same October 17, 2025 private placement, accounting for anti-dilution and reset provisions. Both proposals are crucial for RENX to comply with Nasdaq Rule 5635(d) and avoid potential delisting or other penalties. The Board of Directors unanimously recommends a 'FOR' vote on both proposals, as well as an Adjournment Proposal to ensure sufficient proxy solicitation if needed. The total potential dilution from these issuances could be substantial, impacting existing shareholders.

Why It Matters

This DEF 14A filing is critical for RENX investors as it outlines proposals that could lead to significant dilution of existing common stock. The potential issuance of up to 53,925,620 shares from Series B Preferred Stock conversion and 37,190,083 shares from warrant exercises, totaling over 91 million new shares, could substantially depress the per-share value for current shareholders. For the company, approval is essential to maintain compliance with Nasdaq Rule 5635(d) and avoid regulatory repercussions, which could impact its ability to raise future capital and its market credibility. Competitors in the modular construction and development space will be watching to see if RENX can successfully navigate this capital structure change without severe market backlash.

Risk Assessment

Risk Level: high — The risk level is high due to the potential for significant dilution. The company is seeking approval to issue up to 53,925,620 shares of common stock from Series B Preferred Stock conversion and up to 37,190,083 shares from warrant exercises, totaling 91,115,703 shares. This substantial increase in outstanding shares, compared to the 8,882,672 shares outstanding as of the November 18, 2025 Record Date, could severely dilute existing shareholder value.

Analyst Insight

Investors should carefully consider the significant dilutive impact of these proposals on their holdings. While voting 'FOR' is recommended by the board to ensure Nasdaq compliance, shareholders should be prepared for potential downward pressure on RENX's stock price if these proposals pass and the new shares are issued. Evaluate your position based on your risk tolerance and long-term outlook for the company.

Key Numbers

• 53,925,620 — Maximum Common Stock shares from Series B conversion (Potential dilution from Series B Preferred Stock conversion)
• 37,190,083 — Maximum Common Stock shares from Warrant exercise (Potential dilution from common warrant exercise)
• 360,000 — Shares of Series B Preferred Stock (Issued in private placement on October 17, 2025)
• October 17, 2025 — Date of private placement closing (Date when Series B Preferred Stock and Warrants were issued)
• December 8, 2025 — Date of Special Meeting of Stockholders (Meeting to vote on conversion and exercise proposals)
• November 18, 2025 — Record Date for voting (Date for determining stockholders entitled to vote)
• 8,882,672 — Shares of Common Stock outstanding (As of the Record Date, November 18, 2025)
• 34% — Quorum requirement (Percentage of outstanding shares needed for a quorum)

Key Players & Entities

• Safe & Green Development Corp (company) — Registrant
• Nasdaq (regulator) — Exchange requiring approval under Rule 5635(d)
• David Villarreal (person) — Chief Executive Officer and Director of Safe & Green Development Corp
• Blank Rome LLP (company) — Location of the Special Meeting of Stockholders
• Equiniti Trust Company LLC (company) — Transfer agent for SG DevCo
• New York Stock Exchange (regulator) — Exchange whose rules define 'routine' matters for broker voting
• $0.001 (dollar_amount) — Par value per share for Common Stock and Series B Preferred Stock

FAQ

Risk Factors

• Nasdaq Listing Compliance [high — regulatory]: The company is seeking stockholder approval for the issuance of up to 53,925,620 shares from Series B Preferred Stock conversion and up to 37,190,083 shares from warrant exercises. These issuances are critical to comply with Nasdaq Rule 5635(d), which requires shareholder approval for issuances exceeding 20% of the outstanding common stock. Failure to obtain approval could lead to delisting from the Nasdaq Capital Market.
• Significant Shareholder Dilution [high — financial]: The potential issuance of up to 53,925,620 shares from Series B Preferred Stock conversion and 37,190,083 shares from warrant exercises represents a substantial dilution to existing shareholders. As of November 18, 2025, there were 8,882,672 shares of Common Stock outstanding. The combined potential issuance could represent over 100% of the current outstanding shares, significantly reducing the ownership percentage of existing stockholders.
• Conversion Price Reset Provisions [medium — financial]: The Series B Preferred Stock has conversion price reset provisions. If the conversion price is reduced to the floor price due to dilutive issuances or other reset triggers, the number of shares issued upon conversion could increase. This mechanism, along with make-whole provisions and dividend issuances, contributes to the maximum potential share count of 53,925,620.

Industry Context

Safe & Green Development Corp operates in the real estate development sector, likely focusing on sustainable or green building initiatives. This sector is influenced by economic cycles, interest rates, and increasing demand for environmentally conscious construction. Competition can be intense, with both large established developers and smaller niche players.

Regulatory Implications

The company faces significant regulatory risk related to Nasdaq listing compliance. Failure to secure stockholder approval for the proposed share issuances under Nasdaq Rule 5635(d) could result in delisting, severely impacting liquidity and investor confidence.

What Investors Should Do

1. Vote FOR the Series B Conversion Proposal
2. Vote FOR the Warrant Exercise Proposal
3. Review the potential dilution impact

Key Dates

• 2025-10-17: Closing of Private Placement Offering — Series B Non-Voting Convertible Preferred Stock and common warrants were issued on this date.
• 2025-11-18: Record Date for Special Meeting — Determined the stockholders entitled to vote at the Special Meeting. As of this date, 8,882,672 shares of Common Stock were outstanding.
• 2025-12-08: Special Meeting of Stockholders — Stockholders will vote on the Series B Conversion Proposal and the Warrant Exercise Proposal, crucial for Nasdaq compliance.

Glossary

Series B Non-Voting Convertible Preferred Stock

A class of preferred stock that carries no voting rights but can be converted into shares of common stock under certain conditions. (The conversion of these 360,000 shares is a primary subject of the Special Meeting, potentially leading to significant dilution.)

Floor Price

The minimum price at which a security can be converted or exercised, often used in convertible securities to protect against excessive dilution. (The conversion price of the Series B Preferred Stock may be reduced to this floor price, increasing the number of shares issued.)

Make-Whole Provision

A clause in a convertible security that compensates the holder for the loss of future interest or dividends if the security is converted early or under certain circumstances. (This provision can lead to the issuance of additional shares of common stock upon conversion of the Series B Preferred Stock.)

Nasdaq Rule 5635(d)

A Nasdaq listing rule requiring shareholder approval for issuances of securities that equal or exceed 20% of the outstanding common stock or common stock equivalents. (The company needs approval under this rule for the proposed share issuances to maintain its Nasdaq listing.)

Dilutive Issuance

The issuance of new shares of stock that reduces the ownership percentage of existing shareholders and can lower earnings per share. (Dilutive issuances can trigger a reset of the conversion price for the Series B Preferred Stock, increasing potential dilution.)

Year-Over-Year Comparison

This filing is a proxy statement for a special meeting and does not contain comparative financial data typically found in an annual report (10-K) or quarterly report (10-Q). Therefore, a direct comparison of key metrics like revenue growth, margin changes, or financial highlights to a previous period is not possible based on this document alone. The primary focus is on upcoming shareholder votes critical for regulatory compliance.

Key Financial Figures

• $0.001 — s of the Company’s common stock, $0.001 par value per share (“Common Sto

Filing Documents

• ea0262922-02.htm (DEF 14A) — 390KB
• tsafelogo_001.jpg (GRAPHIC) — 55KB
• tproxy_001.jpg (GRAPHIC) — 1477KB
• tproxy_002.jpg (GRAPHIC) — 1042KB
• 0001213900-25-112174.txt ( ) — 3937KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT   19 HOUSEHOLDING   20 STOCKHOLDER PROPOSALS FOR THE 2026 ANNUAL MEETING   21 i Table of Contents 100 Biscayne Blvd., Suite 1201 Miami, Florida 33132 PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 8, 2025 GENERAL INFORMATION We are providing these proxy materials to holders of shares of common stock, $0.001 par value per share (the “Common Stock”), of Safe and Green Development Corporation, a Delaware corporation (referred to as “SG DevCo,” the “Company,” “we,” or “us”), in connection with the solicitation by the Board of Directors (the “Board” or “Board of Directors”) of SG DevCo of proxies to be voted at our Special Meeting of Stockholders (the “Special Meeting”) to be held on December 8, 2025, beginning at 10:00 a.m., local time at the offices of Blank Rome LLP, 1271 Avenue of the Americas, 16 th Floor, New York, New York 10020, and at any adjournment or postponement of our Special Meeting. This proxy statement is being distributed and made available to our stockholders starting on or about November 18, 2025. The purpose of the Special Meeting and the matters to be acted on are summarized below. No other business will come before the Special Meeting. Agenda Item   Board Vote Recommendation   Page Reference To approve, pursuant to Nasdaq Rule 5635(d), the issuance of up to 53,925,620 shares of the Company’s common stock, $0.001 par value per share (“Common Stock”) upon the conversion of the 360,000 shares of the Series B Non-Voting Convertible Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”), which were issued in connection with our private placement offering that closed on October&#

View Full Filing

View this DEF 14A filing on SEC EDGAR